ABBV

ABBVIE
D

ABBV

Arincen73/100B
294.86
USD
9.02
(3.16%)
Post Trading·295.20USD+0.34(+0.12%)
Last updated: · Delayed 15 min
Fair value398.80Plus-26%299Price 294.86499
Q4 FY2026 · Earnings report
EPS estimate 3.89Revenue estimate 18.33B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

ABBVIE executives and insider trading

Robert A. Michael reported no open-market purchases or sales over the last twelve months.

Over the last twelve months ABBVIE's insiders sold 78,989 shares for 18.92M USD in 6 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
6
Shares sold
78,989
Value sold
18.92M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
8.18M USD
0
6 months
8.18M USD
0
1 year
18.92M USD
0
2 years
88.01M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Perry C. Siatis Executive Vice President, General Counsel & Secretary5141,0499.52M USD—2 Mar 2026—
Nicholas J. Donoghoe Executive Vice President and Chief Business & Strategy Officer4532,7108.18M USD—14 Aug 2026—
David Ryan Purdue SVP, Controller—5,2301.22M USD—4 Mar 2026—

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
14 Aug 2026Nicholas J. DonoghoeSale32,710250.008.18M USD74,430Form 4
4 Mar 2026David Ryan PurdueSale5,230233.561.22M USD2,654Form 4
2 Mar 2026Perry C. SiatisSale5,777233.511.35M USD17,510Form 4
2 Mar 2026Perry C. SiatisSale10,291234.662.41M USD7,219Form 4
2 Mar 2026Perry C. SiatisSale2,600235.26611.68K USD4,619Form 4
25 Feb 2026Perry C. SiatisSale22,381230.005.15M USD38,137Form 4
12 Aug 2025Azita Saleki-gerhardtSale42,370198.428.41M USD177,292Form 4
5 Aug 2025Nicholas J. DonoghoeSale3,234198.27641.24K USD68,308Form 4
5 Aug 2025Nicholas J. DonoghoeSale10,061198.592.00M USD58,247Form 4
31 Mar 2025Jeffrey Ryan StewartSale25,700209.495.38M USD86,366Form 4
31 Mar 2025Jeffrey Ryan StewartSale33,132210.546.98M USD53,234Form 4
14 Mar 2025Scott T. ReentsSale17,644212.343.75M USD11,577Form 4
3 Mar 2025Richard A GonzalezSale6,168210.531.30M USD388,929Form 4
3 Mar 2025Perry C. SiatisSale18,008210.003.78M USD4,619Form 4
3 Mar 2025Timothy J. RichmondSale5,677209.801.19M USD21,703Form 4

Common questions about ABBVIE's executives and insiders

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.